A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Proof-of-Concept Study to Evaluate the Safety and Analgesic Efficacy of MAX-001 in Participants Undergoing Extraction of Bilateral Impacted Mandibular Third Molar Teeth | Arctuva